JPRN-UMIN000006163已完成未知
Phase II study of adjuvant chemotherapy with gemcitabine and regional arterial infusion of nafamostat mesilate for the patients with resectable pancreatic cancer - Chemotherapy with gemcitabine and nafamostat mesilate for the patients with resectable pancreatic cancer
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Pulmonary fibrosis or interstitial pneumonia detectable on chest X-ray 2)Active infection 3)Uncontrollable heart disease and myocardial infarction within 6 months 4)Uncontrollable DM 5)Pregnant or lactation women, or women with known or suspected pregnancy 6)History of severe drug allergy 7)Active synchronous or metachronous malignancy 8)Severe complications after operation 9)No chemotherapy or radiotherapy for pancreatic cancer in the past 10)Patients who are judged inappropriate for the entry into the study by the investigater
研究者
相似试验
招募中
不适用
A Phase I study of adjuvant chemotherapy with gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomyBiliary tract cancer undergoing curative resection without major hepatectomyJPRN-UMIN000007454Kansai Hepatobiliary Oncology Group (KHBO)24
已完成
不适用
A Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomyBiliary tract cancer undergoing curative resection without major hepatectomyJPRN-UMIN000004622Kansai Hepatobiliary Oncology Group (KHBO)24
已完成
1 期
Phase I study of neoadjuvant chemotherapy of gemcitabine plus nab-paclitaxel for patients with borderline resectable pancreatic cancerInvasive ductal carcinomaJPRN-UMIN000018382Wakayama Medical University10
已完成
不适用
Phase II study of induction chemotherapy with gemcitabine and S-1 followed by chemoradiotherapy with S-1 in patients with locally advanced pancreatic cancerlocally advanced pancreatic cancerJPRN-UMIN000006332Chiba Cancer Center30
已完成
2 期
Phase II study of Neoadjuvant chemotherapy with Gemcitabine and S1 (GS therapy) for resectable pancreatic carcinoma (NAC GS2+2)resectable pancreatic cancerJPRN-UMIN000009070EXTSURG35